Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic

被引:166
作者
De Valle, M. B. [1 ]
Klinteberg, V. Av [1 ]
Alem, N. [1 ]
Olsson, R. [1 ]
Bjornsson, E. [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Internal Med, Sect Gastroenterol & Hepatol, SE-41345 Gothenburg, Sweden
关键词
D O I
10.1111/j.1365-2036.2006.03117.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Limited data exist on the proportion of drug-induced liver injury among out-patients seen in a hepatology clinic. Aim To determine the proportion of drug-induced liver injury cases, and identify the most important agents and the nature of the liver injury. Methods A computerized diagnoses database in an out-patient hepatology clinic in a Swedish University hospital was analysed during the period 1995-2005. All suspected drug-induced liver injury cases were causality assessed with the International Consensus Criteria. Results A total of 1164 cases were seen for the first time during this period. Drug-induced liver injury with at least a possible causal relationship was found in 77 cases (6.6%), 38 (3.3%) of whom were referred for evaluation to the out-patient clinic whereas 3% had a follow-up after hospitalization of drug-induced liver injury. The median age was 58 years, 43 (56%) were females, a hepatocellular pattern was observed in 37 cases (48%), cholestatic in 31 (40%) and mixed in 12%. Antibiotics were the most common agents causing drug-induced liver injury followed by non-steroidal anti-inflammatory drugs, with diclofenac most often responsible for the drug-induced liver injury. Conclusions Drug-induced liver injury cases constituted 6% of all out-patients and 3% of referrals and occurred more often in women. Antibiotics and diclofenac were the most common causes of drug-induced liver injury among out-patients.
引用
收藏
页码:1187 / 1195
页数:9
相关论文
共 38 条
[1]   Accuracy of hepatic adverse drug reaction reporting in one English health region [J].
Aithal, GP ;
Rawlins, MD ;
Day, CP .
BRITISH MEDICAL JOURNAL, 1999, 319 (7224) :1541-1541
[2]   The natural history of histologically proved drug induced liver disease [J].
Aithal, PG ;
Day, CP .
GUT, 1999, 44 (05) :731-735
[3]  
Andrade Raul J, 2004, Expert Opin Drug Saf, V3, P329, DOI 10.1517/14740338.3.4.329
[4]  
Andrade RJ, 2005, GASTROENTEROLOGY, V129, P1808
[5]   DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE [J].
BAKKE, OM ;
MANOCCHIA, M ;
DEABAJO, F ;
KAITIN, KI ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :108-117
[6]  
BANKS AT, 1995, HEPATOLOGY, V22, P820, DOI 10.1002/hep.1840220320
[7]  
BENICHOU C, 1990, J HEPATOL, V11, P272
[8]   Suspected drug-induced liver fatalities reported to the WHO database [J].
Björnsson, E ;
Olsson, R .
DIGESTIVE AND LIVER DISEASE, 2006, 38 (01) :33-38
[9]   Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden [J].
Björnsson, E ;
Jerlstad, P ;
Bergqvist, A ;
Olsson, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (09) :1095-1101
[10]   Outcome and prognostic markers in severe drug-induced liver disease [J].
Björnsson, E ;
Olsson, R .
HEPATOLOGY, 2005, 42 (02) :481-489